Previous close | 7.85 |
Open | 7.89 |
Bid | 7.80 x 100 |
Ask | 7.84 x 100 |
Day's range | 7.44 - 8.03 |
52-week range | 4.46 - 9.20 |
Volume | |
Avg. volume | 911,469 |
Market cap | 1.495B |
Beta (5Y monthly) | 1.44 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
ORANGE, Calif., June 24, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced that the Centers for Medicare and Medicaid Services (CMS) recalculated the 2024 Star Rating of its H5296 Medicare Advantage (MA) HMO contract in North Carolina and Nevada, resulting in a 5-star out of a possible 5-star rating. Every year, CMS evaluates plans based on a 5-star rating, with 5 stars representing “excellent” performance. “We’re pleased that CMS has revised the rating of our HM
ORANGE, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that John Kao, founder and CEO, and Thomas Freeman, chief financial officer, will present at William Blair's 44th Annual Growth Stock Conference in Chicago on Wednesday, June 5, at 12:40 p.m. CDT. A webcast and replay of the presentation will be available on Alignment’s investor relations website at https://ir.alignmenthealth.com/. About Alignment HealthcareAlignment Health is championing
Reports $628.6 million in total revenue and $627.6 million in revenue excluding ACO REACH, up 43.1% and 54.2% year-over-year respectivelyMedicare Advantage membership grows 50.5% year-over-year to approximately 165,100 membersIncreases membership and revenue outlook following strong first-quarter enrollment results, narrows year-end adjusted EBITDA guidance range ORANGE, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today reported financial results for its f